Gf Fund Management Co. Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 9,775 shares of RXRX stock, worth $49,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,775
Previous 8,016
21.94%
Holding current value
$49,168
Previous $54.2 Million
4.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$175 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$162 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$123 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$87.1 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$73.8 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $908M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...